The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
โ Scribed by Glen Lutchman; Apurva Modi; David E. Kleiner; Kittichai Promrat; Theo Heller; Marc Ghany; Brian Borg; Rohit Loomba; T. Jake Liang; Ahalya Premkumar; Jay H. Hoofnagle
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 236 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The role of ethnicity in determining disease severity in nonalcoholic steatohepatitis (NASH) remains unclear. We recruited 152 patients with biopsy-proven NASH, 63% of whom were Hispanic and 37% of whom were Caucasian. Both groups were well matched for age, sex, and total body fat. We measured: (1)
Because of the ongoing epidemics of obesity and diabetes, nonalcoholic steatohepatitis (NASH) may become a leading indication for liver transplantation. There are concerns about the posttransplant survival of patients with NASH because of associated cardiovascular and metabolic risk factors. We aime
We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong